Akebia Therapeutics (AKBA) Interest & Investment Income (2014 - 2019)
Akebia Therapeutics (AKBA) posted quarterly Interest & Investment Income of -$6000.0 for Q4 2019, down 104.05% year-over-year from $148000.0 in Q4 2018, and up 64.71% quarter-over-quarter from -$17000.0 in Q3 2019.
Akebia Therapeutics (AKBA) Interest & Investment Income (2014 - 2019) Analysis & Trends
Akebia Therapeutics (AKBA) has reported Interest & Investment Income for 6 consecutive years, with -$6000.0 the latest figure, recorded in Q4 2019.
- In Q4 2019, Interest & Investment Income fell 104.05% year-over-year to -$6000.0; the TTM figure through Dec 2019 stood at $261000.0 (up 44.2% YoY), while the FY2019 annual figure was $261000.0, up 44.2% from the prior year.
- Interest & Investment Income improved to -$6000.0 in Q4 2019 per AKBA's latest filing, from -$17000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $225000.0 in Q1 2019 and bottomed at -$764000.0 in Q4 2016.
- Historically, Interest & Investment Income has averaged -$59250.0 across 5 years, with a median of -$7000.0 in 2015.
- Annual changes were most pronounced in 2015 — Interest & Investment Income jumped 1550.0% — and 2017, when it slumped 588.46%.
- Akebia Therapeutics' Interest & Investment Income stood at -$584000.0 in 2015, then plunged by 30.82% to -$764000.0 in 2016, then soared by 71.34% to -$219000.0 in 2017, then soared by 167.58% to $148000.0 in 2018, then tumbled by 104.05% to -$6000.0 in 2019.
- Business Quant data shows AKBA's Interest & Investment Income at -$6000.0 in Q4 2019, -$17000.0 in Q3 2019, and $59000.0 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 154.39 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 31.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 12.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Akebia Therapeutics | 249.25 Mn | 93.70 Mn | 38.70 Mn | -3.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -6,000.00 |
| Sep 30, 2019 | -17,000.00 |
| Jun 30, 2019 | 59,000.00 |
| Mar 31, 2019 | 225,000.00 |
| Dec 31, 2018 | 148,000.00 |
| Sep 30, 2018 | 50,000.00 |
| Jun 30, 2018 | 91,000.00 |
| Mar 31, 2018 | -108,000.00 |
| Dec 31, 2017 | -219,000.00 |
| Sep 30, 2017 | 73,000.00 |
| Jun 30, 2017 | -75,000.00 |
| Mar 31, 2017 | -179,000.00 |
| Dec 31, 2016 | -764,000.00 |
| Sep 30, 2016 | -44,000.00 |
| Jun 30, 2016 | 63,000.00 |
| Mar 31, 2016 | -26,000.00 |
| Dec 31, 2015 | -584,000.00 |
| Sep 30, 2015 | 20,000.00 |
| Jun 30, 2015 | 116,000.00 |
| Mar 31, 2015 | -8,000.00 |